Table 2.
Clinical and imaging manifestations of ACP and SPCP.
| Project | ACP (n=44) M (P25~ P75), n (%) |
SPCP (n=24) M (P25~P75), n (%) |
χ2 | P | |
|---|---|---|---|---|---|
| age | 27 (4~64) | 43 (5~82) | – | <0.001* | |
| Male | 16 (66.7) | 2.805 | 0.094 | ||
| Volume (cm3) | 8.3 (3.20~12.29) | – | 0.197 | ||
| Location | 4.763 | 0.092 | |||
| saddle | 8 (18.2) | 1 (4.2) | |||
| suprasellar | 20 (45.5) | 17 (70.8) | |||
| Saddle and suprasellar | 16 (36.3) | 6 (25.0) | |||
| Texture | 0.037* | ||||
| cystic | 19 (43.2) | 4 (16.7) | |||
| solid | 2 (4.5) | 4 (16.7) | |||
| cystic-solid | 23 (52.3) | 16 (66.6) | |||
| Necrosis | 23 (52.3) | 13 (54.2) | 0.022 | 0.881 | |
| Liquid level or sediment | 9 (20.5) | 0 (0.0) | – | 0.022* | |
| Calcification | 19 (43.2) | 6 (25.0) | 2.208 | 0.137 | |
| Supratentorial hydrocephalus | 18 (40.9) | 8 (33.3) | 0.377 | 0.539 | |
| Pituitary involvement | 30 (68.2) | 21 (87.5) | 3.091 | 0.079 | |
| Pituitary stalk involvement | 7 (15.9) | 7 (29.2) | – | 0.222 | |
| Hypothalamus involvement before Puget surgery | 39 (88.6) | 22 (91.6) | – | 1.000 | |
*In the table indicates a statistically significant comparison. ACP, adamantinomatous craniopharyngioma; SPCP, squamous papillary craniopharyngioma.